Belgian (BEL20) Growth Pharmaceuticals & Biotech Stocks
UPDATED May 08, 2026
Discover Belgian Pharmaceuticals & Biotech Growth Stocks that are on the BEL20. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
HYL | €5.16 | 6.4% | -9.6% | €147.3m | €13.57 | 16.4 | 87.6% | n/a | ||
ARGX | €670.80 | 0.4% | 35.2% | €41.7b | €844.01 | 33.0 | 21.9% | n/a | ||
UCB | €234.10 | 1.3% | 51.7% | €44.3b | €288.21 | 28.6 | 17.2% | 0.6% | ||
ALEMS | €4.90 | -6.7% | -10.9% | €20.7m | n/a | 11.3 | n/a | n/a | ||
CYAD | €0.30 | -2.9% | -34.3% | €14.1m | n/a | 16.3 | n/a | n/a | ||
BIOS | €0.0022 | 0% | 46.7% | €1.4m | n/a | -0.4 | n/a | n/a | ||
OXUR | €0.0038 | 0% | -94.6% | €337.0k | n/a | 0.2 | n/a | n/a | ||
TUB | €200.40 | 2.4% | 64.3% | €8.9b | €286.00 | 95.7 | n/a | 0.5% |
Page 1 of 1